These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17575127)

  • 41. Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest.
    Tiainen M; Ylikorkala A; Mäkelä TP
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9248-51. PubMed ID: 10430928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer.
    Upadhyay S; Liu C; Chatterjee A; Hoque MO; Kim MS; Engles J; Westra W; Trink B; Ratovitski E; Sidransky D
    Cancer Res; 2006 Aug; 66(16):7870-9. PubMed ID: 16912160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth and molecular profile of lung cancer cells expressing ectopic LKB1: down-regulation of the phosphatidylinositol 3'-phosphate kinase/PTEN pathway.
    Jimenez AI; Fernandez P; Dominguez O; Dopazo A; Sanchez-Cespedes M
    Cancer Res; 2003 Mar; 63(6):1382-8. PubMed ID: 12649203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours.
    Rowan A; Churchman M; Jefferey R; Hanby A; Poulsom R; Tomlinson I
    J Pathol; 2000 Oct; 192(2):203-6. PubMed ID: 11004696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of LKB1 suppresses Stat3 activity to promote the proliferation of esophageal carcinoma cells.
    Wang YQ; Dai WM; Chu XY; Yang B; Zhao M; Sun Y
    Mol Med Rep; 2014 Jun; 9(6):2400-4. PubMed ID: 24676538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous LKB1 knockdown accelerates G(1)/S transition through p53 and p16 pathways.
    Liang X; Wang P; Gao Q; Xiang T; Tao X
    Cancer Biol Ther; 2010 Jan; 9(2):156-60. PubMed ID: 20368693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LKB1 catalytic activity contributes to estrogen receptor alpha signaling.
    Nath-Sain S; Marignani PA
    Mol Biol Cell; 2009 Jun; 20(11):2785-95. PubMed ID: 19369417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice.
    Nakau M; Miyoshi H; Seldin MF; Imamura M; Oshima M; Taketo MM
    Cancer Res; 2002 Aug; 62(16):4549-53. PubMed ID: 12183403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LKB1 protein expression in the evolution of glandular neoplasia of the lung.
    Ghaffar H; Sahin F; Sanchez-Cepedes M; Su GH; Zahurak M; Sidransky D; Westra WH
    Clin Cancer Res; 2003 Aug; 9(8):2998-3003. PubMed ID: 12912948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. STK11/LKB1 germline mutations in the first Peutz-Jeghers syndrome patients identified in Slovakia.
    Bartosova Z; Zavodna K; Krivulcik T; Usak J; Mlkva I; Kruzliak T; Hromec J; Usakova V; Kopecka I; Veres P; Bartosova Z; Bujalkova M
    Neoplasma; 2007; 54(2):101-7. PubMed ID: 17319781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ganglioglioma arising in a Peutz-Jeghers patient: a case report with molecular implications.
    Resta N; Lauriola L; Puca A; Susca FC; Albanese A; Sabatino G; Di Giacomo MC; Gessi M; Guanti G
    Acta Neuropathol; 2006 Jul; 112(1):106-11. PubMed ID: 16733653
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Loss of LKB1 in high-grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53.
    Co NN; Iglesias D; Celestino J; Kwan SY; Mok SC; Schmandt R; Lu KH
    Cancer; 2014 Nov; 120(22):3457-68. PubMed ID: 25042259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of LKB1 with a WD-repeat protein WDR6 is implicated in cell growth arrest and p27(Kip1) induction.
    Xie X; Wang Z; Chen Y
    Mol Cell Biochem; 2007 Jul; 301(1-2):115-22. PubMed ID: 17216128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LKB1--a master tumour suppressor of the small intestine and beyond.
    Yoo LI; Chung DC; Yuan J
    Nat Rev Cancer; 2002 Jul; 2(7):529-35. PubMed ID: 12094239
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical significance and role of LKB1 in gastric cancer.
    Jiang S; Chen R; Yu J; Li N; Ke R; Luo L; Zou J; Zhang J; Zhang K; Lu N; Huang D
    Mol Med Rep; 2016 Jan; 13(1):249-56. PubMed ID: 26549522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel splice isoforms of STRADalpha differentially affect LKB1 activity, complex assembly and subcellular localization.
    Marignani PA; Scott KD; Bagnulo R; Cannone D; Ferrari E; Stella A; Guanti G; Simone C; Resta N
    Cancer Biol Ther; 2007 Oct; 6(10):1627-31. PubMed ID: 17921699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Overexpression of PDZ domain-containing protein AIE-75 induces G2/M cell cycle arrest in human colorectal adenocarcinoma SW480 cells].
    Hirai A
    Hokkaido Igaku Zasshi; 2002 May; 77(3):239-49. PubMed ID: 12056051
    [No Abstract]   [Full Text] [Related]  

  • 58. 3D view to tumor suppression: Lkb1, polarity and the arrest of oncogenic c-Myc.
    Partanen JI; Nieminen AI; Klefstrom J
    Cell Cycle; 2009 Mar; 8(5):716-24. PubMed ID: 19221484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular mechanisms of LKB1 induced cell cycle arrest.
    Zhong DS; Sun LL; Dong LX
    Thorac Cancer; 2013 Aug; 4(3):229-233. PubMed ID: 28920233
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines.
    Mack HI; Munger K
    Virology; 2013 Nov; 446(1-2):9-16. PubMed ID: 24074562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.